July 06, 2010
The FDA has approved Zuplenz (ondansetron oral soluble film, from Strativa) for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting.
June 01, 2010
The FDA has notified healthcare professionals not to use the intravenous medications, metronidazole, ciprofloxacin and ondansetron manufactured by Claris Lifesciences due to contamination.
May 11, 2010
The FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) has launched the Bad Ad Program, designed to educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful, and not misleading.
March 25, 2010
The FDA has approved Xifaxan (rifaximin tablets, from Salix Pharmaceuticals) 550mg for the reduction in risk of recurrence of overt hepatic encephalopathy in patients ≥18 years of age with advanced liver disease.
January 29, 2010
Sato Pharmaceutical has made available over-the-counter Zentrip (meclizine HCl quick-dissolving strips) for the prevention and relief of nausea, vomiting, and dizziness associated with motion sickness.